News

Sales of Olainfarm in May Increase by 8%

on June 18, 2012

Preliminary consolidated sales results of JSC Olainfarm for May show that sales have increased to 3.18 million lats (4.53 million euro) which is by 8% more compared to the same period one year ago. Biggest sales increases were achieved in Kyrgyzstan – by 276%, Latvia – by 257%, Azerbaijan – by 121% and Belarus by 113%. Major sales markets of JSC Olainfarm in May of 2012 were Russia, Latvia, Ukraine, Belarus, Kazakhstan and the UK.

May 2012,
consolidated results
Changes to May 2011 Share in total sales
Russia

8%

35%

Latvia

257%

22%

Ukraine

-59%

14%

Belarus

113%

9%

Kazakhstan

14%

7%

UK

NA

6%

Azerbaijan

121%

1%

Canada

NA

1%

Kyrgyzstan

276%

1%

Uzbekistan

-79%

1%

Other

-44%

3%

Total

8%

100%

 

In five months of 2012 preliminary consolidates sales of JSC Olainfarm were 18.43 million lats (26.23 million euros), which is an increase by 27% compared to the sale period of 2011. Impressive sales increases were achieved in US, where sales increased 344 times, Taiwan and Latvia where sales grew fourfold. Major sales markets of JSC Olainfarm in five months of 2012 were Russia, Ukraine, Latvia, Belarus, UK and Kazakhstan.

5 months of 2012 -consolidated results Changes to five months of 2011 Share in total sales
Russia 21% 36%
Ukraine 8% 20%
Latvia 315% 20%
Belarus -20% 6%
UK 25% 5%
Kazakhstan 11% 4%
Uzbekistan -30% 1%
Taiwan 311% 1%
USA 34367% 1%
Lithuania -25% 1%
Other -25% 6%
Total 27% 100%

 

Sales of pharmacies owned by JSC Olainfarm in May 2012 were 0.53 million lats (0.75 million euro). In fine months of 2012 sales of these pharmacies were 2.64 million lats (3.77 million euro).

According to preliminary data, unconsolidated sales of JSC Olainfarm in May 2012 were 2.68 million lats (3.82 million euro). This is a decrease by 9% compared to the same period a year ago. Biggest sales increases were achieved in Kyrgyzstan – by 276%, Azerbaijan – by 121% and Belarus by 113%. Major markets of JSC Olainfarm for unconsolidated sales in May 2012 were Russia, Ukraine, Belarus, Latvia, Kazakhstan and the UK.

May 2012, unconsolidated results Changes to May 2012 Share in total sales
Russia 8% 41%
Ukraine -59% 16%
Belarus 113% 11%
Latvia 7% 8%
Kazakhstan 14% 8%
UK NA 7%
Azerbaijan 121% 2%
Canada NA 1%
Kyrgyzstan 276% 1%
Uzbekistan -79% 1%
Other -44% 4%
Total -9% 100%

 

In five months of 2012 preliminary unconsolidated sales of JSC Olainfarm were 15.89 million lats (22.60 million euro), which is an increase by 9% compared to the same period of 2011. Impressive sales increases were achieved in US, where sales increased 344 times, Taiwan and Latvia where sales grew fourfold. Major sales markets of JSC Olainfarm in five months of 2012 were Russia, Ukraine, Latvia, Belarus, UK and Kazakhstan.

5 months of 2012, unconsolidated results Changes to 5 months of 2011 Share in total sales
Russia 21% 41%
Ukraine 8% 23%
Belarus -20% 7%
Latvia 22% 7%
UK 25% 6%
Kazakhstan 11% 5%
Uzbekistan -30% 1%
Taiwan 311% 1%
USA 34367% 1%
Lithuania -25% 1%
Other -25% 7%
Total 9% 100%

 

Sales forecasts of JSC Olainfarm for 2012 provide that unconsolidated sales of the company in 2012 will reach 40 million lats (56.91 million euro), while the consolidated sales will be as high as 47 million lats (66.9 million euro). According to these preliminary unaudited unconsolidated results, during 5 months of 2012 nearly 40% of annual unconsolidated sales target are met, while according to preliminary consolidated sales results, during 5 months of 2012 39% of annual consolidated sales target is achieved.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

 

SigitaSales of Olainfarm in May Increase by 8%